What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Eric Baudin mainly focuses on Internal medicine, Endocrinology, Thyroid carcinoma, Pathology and Thyroid.
The study incorporates disciplines such as Gastroenterology, Surgery and Oncology in addition to Internal medicine.
His Surgery research is multidisciplinary, relying on both Octreotide and Carcinoid syndrome.
His work on Thyroid cancer and Medullary carcinoma as part of his general Endocrinology study is frequently connected to Context, thereby bridging the divide between different branches of science.
As a part of the same scientific family, Eric Baudin mostly works in the field of Pathology, focusing on Metastasis and, on occasion, Treatment modality.
His research in Thyroid intersects with topics in Radiation therapy, Neck dissection and Lymph node.
His most cited work include:
- Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma : benefits and limits of radioiodine therapy (918 citations)
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial (898 citations)
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study (746 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Oncology, Neuroendocrine tumors and Pathology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery.
Eric Baudin combines subjects such as Cancer and Chromogranin A with his study of Endocrinology.
His Oncology research includes elements of Prospective cohort study, Chemotherapy, Paraganglioma and Endocrine system.
Eric Baudin works mostly in the field of Neuroendocrine tumors, limiting it down to topics relating to Metastasis and, in certain cases, Radiology.
His Thyroid carcinoma research integrates issues from Medullary cavity, Carcinoma and Lymph node.
He most often published in these fields:
- Internal medicine (61.67%)
- Endocrinology (27.67%)
- Oncology (22.77%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (61.67%)
- Oncology (22.77%)
- Neuroendocrine tumors (17.87%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Neuroendocrine tumors, Paraganglioma and Gastroenterology are his primary areas of study.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
His study in Oncology is interdisciplinary in nature, drawing from both Etoposide, Adrenocortical carcinoma, Adjuvant therapy and Endocrine system.
The concepts of his Neuroendocrine tumors study are interwoven with issues in Cancer stem cell, Radionuclide therapy, Pancreas, Primary tumor and Diagnosis management.
His Paraganglioma research also works with subjects such as
- Pheochromocytoma which intersects with area such as SDHB, Radiology, Survival rate and Natural history,
- DNA sequencing and related Mutation rate, Germline, Mutation and Computational biology.
His Gastroenterology research incorporates elements of Neutropenia, Objective response, Phases of clinical research and Tumor growth.
Between 2018 and 2021, his most popular works were:
- Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study (32 citations)
- Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3) (29 citations)
- Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. (28 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Internal medicine, Oncology, Neuroendocrine tumors, Paraganglioma and Retrospective cohort study.
The study of Internal medicine is intertwined with the study of Gastroenterology in a number of ways.
His Oncology study integrates concerns from other disciplines, such as Tumour classification, Atypical carcinoid, Clinical trial and Ectopic ACTH syndrome.
His study explores the link between Neuroendocrine tumors and topics such as Endocrine system that cross with problems in Lymph node and Clinical endpoint.
Eric Baudin interconnects Germline, Mutation rate, Prospective cohort study, DNA sequencing and Genetic testing in the investigation of issues within Paraganglioma.
His research integrates issues of Mutation, Survival rate, Thyroidectomy, Natural history and Multiple endocrine neoplasia type 2b in his study of Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
